A detailed history of Boston Common Asset Management, LLC transactions in Csl LTD stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 40,182 shares of CSLLY stock, worth $3.73 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
40,182
Previous 41,067 2.16%
Holding current value
$3.73 Million
Previous $4.05 Million 1.43%
% of portfolio
0.1%
Previous 0.1%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$97.0 - $105.54 $85,845 - $93,402
-885 Reduced 2.16%
40,182 $3.99 Million
Q2 2024

Jul 08, 2024

SELL
$86.82 - $98.5 $238,234 - $270,284
-2,744 Reduced 6.26%
41,067 $4.05 Million
Q1 2024

Apr 11, 2024

BUY
$89.91 - $99.41 $925,803 - $1.02 Million
10,297 Added 30.72%
43,811 $4.12 Million
Q4 2023

Jan 09, 2024

BUY
$73.1 - $97.93 $1.69 Million - $2.27 Million
23,137 Added 222.96%
33,514 $3.28 Million
Q3 2023

Oct 11, 2023

BUY
$80.15 - $92.62 $109,244 - $126,241
1,363 Added 15.12%
10,377 $840,000
Q2 2023

Jul 24, 2023

SELL
$91.49 - $104.64 $15,553 - $17,788
-170 Reduced 1.85%
9,014 $832,000
Q1 2023

May 17, 2023

BUY
$92.92 - $109.35 $23,230 - $27,337
250 Added 2.8%
9,184 $887,000
Q4 2022

Jan 26, 2023

SELL
$84.9 - $102.89 $2,037 - $2,469
-24 Reduced 0.27%
8,934 $872,000
Q3 2022

Oct 20, 2022

SELL
$90.51 - $207.38 $48,513 - $111,155
-536 Reduced 5.65%
8,958 $821,000
Q2 2022

Aug 10, 2022

BUY
$87.94 - $101.67 $371,018 - $428,945
4,219 Added 79.98%
9,494 $878,000
Q1 2022

May 16, 2022

SELL
$85.56 - $107.12 $26,181 - $32,778
-306 Reduced 5.48%
5,275 $526,000
Q4 2021

Jan 31, 2022

BUY
$97.41 - $116.74 $31,853 - $38,173
327 Added 6.22%
5,581 $590,000
Q3 2021

Nov 12, 2021

BUY
$101.72 - $114.56 $32,346 - $36,430
318 Added 6.44%
5,254 $557,000
Q2 2021

Aug 19, 2021

SELL
$100.62 - $116.66 $4,427 - $5,133
-44 Reduced 0.88%
4,936 $524,000
Q1 2021

May 14, 2021

BUY
$95.11 - $111.11 $190,980 - $223,108
2,008 Added 67.56%
4,980 $504,000
Q4 2020

Feb 05, 2021

BUY
$101.34 - $117.74 $44,184 - $51,334
436 Added 17.19%
2,972 $325,000
Q3 2020

Nov 10, 2020

SELL
$95.79 - $111.95 $176,349 - $206,099
-1,841 Reduced 42.06%
2,536 $261,000
Q2 2020

Aug 10, 2020

BUY
$90.75 - $104.91 $397,212 - $459,191
4,377 New
4,377 $432,000

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $89.6B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.